George Clinical

18 articles about George Clinical

• 

  BioSpace Movers & Shakers, Oct. 22

  10/22/2021

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

• Oncologist Herbert Loong Joins George Clinical Scientific Leadership

  1/18/2021

   Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong , has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.

• Abby Abraham Joins George Clinical to lead Global Data Science and head India Business

  10/8/2020

  Abby Abraham, a veteran clinical researcher and data science lead, has joined George Clinical, a global scientifically-backed clinical research organization, to head up the organization's Global Data Science team and operations in India.

• Cancer Specialist Dipti Talaulikar Joins George Clinical Scientific Leadership

  9/21/2020

  Dipti Talaulikar, MBBS, PhD, a clinician and researcher with extensive involvement in hematology, has joined George Clinical, a global scientifically-backed clinical research organization, as a member of the organization's scientific leadership.

• George Clinical Adds CRO Business Development and Operations Veteran to Lead Efforts in China

  9/2/2020

  George Clinical, a global scientifically-backed clinical research organization, has expanded the organization's team in China with the addition of Dr. Zhenfei Yin in the role of Country Head and Regional Head of Project Operations.

• George Clinical Commences New International COVID-19 Study Focused on Protective Measures for At-Risk Patients

  4/30/2020

  George Clinical, a global scientifically-backed clinical research organization, is collaborating with Saint Luke's Mid America Heart Institute on a new study which will explore whether dapagliflozin can prevent disease progression in patients hospitalized with COVID-19 and at high risk for complications due to pre-existing cardio metabolic risk factors.

• George Clinical Providing Critical Clinical Trial Services and Experts for Potential COVID-19 Treatments

  4/2/2020

  George Clinical, a global scientifically-backed clinical research organization, is leveraging the organization's significant health and medical expertise, operational infrastructure and data science teams to actively advise stakeholders on potential COVID-19 vaccine and treatment studies.

• 

  BioSpace Movers & Shakers, Feb. 14

  2/14/2020

  Biopharma and life sciences companies bolster their leadership teams and board with this week's Movers & Shakers.

• George Clinical Names James Cheong Chief Executive Officer

  2/12/2020

  SYDNEY , Feb. 12, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has named James Cheong to the role of Chief Executive Officer. Cheong was hired as Chief Operating Officer at the beginning of 2019 and has overseen substantial growth of the business, leadership team and international footprint.  Cheong succeeds Glenn Kerk

• George Clinical and Guangdong Provincial People's Hospital to Collaborate in Clinical Research

  12/19/2019

  George Clinical, a global scientifically-backed clinical research organization, and Guangdong Provincial People's Hospital have executed a memorandum of understanding laying out broad collaboration in the area of clinical research in China.

• Sean Hart Named Chief Business Officer of George Clinical

  10/9/2019

  Hart, who joined George Clinical through the acquisition of Vector Oncology in 2017, will now lead business development functions globally for the organization.

• George Clinical Grows European Presence with New Location in the United Kingdom

  9/19/2019

  George Clinical, a global scientifically-backed clinical research organization, has expanded its presence in Europe with the opening of a larger and more sophisticated location in the United Kingdom.

• George Clinical Announces the Appointment of Meelian Hoh as Chief Financial Officer

  6/18/2019

  George Clinical, a global scientifically driven CRO, announced the appointment of Meelian Hoh to the role of Chief Financial Officer.

• George Clinical Expands Asia-Pacific Footprint with New Location in the Philippines

  5/29/2019

  George Clinical, a global scientifically-backed clinical research organization, has again expanded its extensive Asia-Pacific footprint through the opening of a new office in the Philippines.

• George Clinical Awarded Taiwanese Drug License

  5/15/2019

  New Status Enhances Clinical Trial Options in the Country

• EPS International and George Clinical Form Strategic Partnership for the Asia-Pacific Region

  4/24/2019

  George Clinical and EPS International Holdings Co., Ltd. announced that they have reached an agreement on a strategic partnership that will enhance their combined service offerings in Asia-Pacific, the world's most populous region, as well as worldwide for their respective clients.

• George Clinical Strengthens Asia-Pacific Presence with New Singapore Location

  4/3/2019

  ames Cheong, appointed last month as COO, is now based out of the office.

• George Clinical Acquires Vector Oncology's Pharma Services

  5/3/2017